Tackling Non-Communicable Diseases In Low- and Middle-Income Countries: Is the Evidence from High-Income Countries All We Need?

Applied health research and development for non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) is limited, and despite repeat calls for action, the NCD burden is increasing unchecked. research in high-income countries (HICs) and LMICs can result in mutual advantages in the areas of replication and extending findings; discovering new causes of NCDs; studying health effects of exposures rare or ubiquitous in HICs; and exploring links between infectious diseases and NCDs. NCDs are at varying stages of needing research, policy development, and action. These stages range from not knowing the population burden of many NCDs to knowing all we need to take action. in the global and national funding agendas will be required to strengthen the research and health system capacity for NCDs, which should reduce deaths and disability attributable to NCDs and yield economic dividends.